サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1424987

組換えDNA技術市場：構成要素別、用途別、エンドユーザー別、国別、地域別 - 産業分析、市場規模、市場シェア、予測、2023-2030年

Recombinant DNA Technology Market, By Component, By Application, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日: | 発行: AnalystView Market Insights | ページ情報: 英文 287 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
組換えDNA技術市場：構成要素別、用途別、エンドユーザー別、国別、地域別 - 産業分析、市場規模、市場シェア、予測、2023-2030年
出版日: 2024年02月07日
発行: AnalystView Market Insights
ページ情報: 英文 287 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

レポートハイライト

組換えDNA技術市場規模は2022年に7,334億1,300万米ドルとなり、2023年から2030年にかけてCAGR 6.5%で拡大

組換えDNA技術市場-市場力学

組換え医薬品と治療薬の生産需要の増加が市場需要を促進

組換え医薬品と治療薬の需要増加に伴う組換えDNAの生産増加により、市場の成長が促進されます。バイオテクノロジー企業や製薬会社は、rDNAの手法をどのように疾患管理の多くの分野に応用できるかを理解しようと取り組んでいます。これは主に、拡大する治療需要に対応し、慢性疾患の負担増と闘うためです。強固なバイオ医薬品パイプライン、特に組換えタンパク質パイプラインの存在は、この技術の利用を促進すると思われます。CRISPR/Cas9ヌクレアーゼ、ZFN、TALENを伴うrDNA技術を用いた組換え製品の開発は、生物による制限を受けることなく、容易かつ正確なゲノム編集を可能にし、この分野の拡大に大きく寄与しています。

がん、糖尿病、感染症のような人間の深刻な病気の治療における業界の進歩は、市場の成長に影響を与える重要な要素の一部です。新しい分子医学、遺伝子治療、薬剤開発のための長時間作用型治療用タンパク質の創出はすべて、組換え技術の進歩から恩恵を受けています。さらに、遺伝性疾患の管理における改善や進行中の市場開拓は、予測期間中の市場成長を後押しすると予想されます。

組換えDNA技術市場-主要インサイト

弊社リサーチアナリストの共有によると、世界市場は予測期間（2023-2030年）に約6.5%のCAGRで毎年成長すると予測されます。

構成要素別では、効率的なタンパク質発現能力により、発現システムセグメントが2022年に最大市場シェアを示すと予測されています。

用途別では、医薬品やワクチンなどの疾患治療に対する需要が大きいことから、健康・疾患分野が2022年の主要分野となりました。

エンドユーザーセグメントに基づくと、製薬＆バイオテクノロジー企業セグメントが、主に医薬品開発数の増加により、2022年の主要セグメントでした。

地域別では、北米が2022年の主要収益源でした。

組換えDNA技術市場-セグメンテーション分析：

組換えDNA技術の世界市場は、構成要素、用途、エンドユーザー、地域に基づいてセグメント化されます。

市場は構成要素に基づいて2つのカテゴリーに分けられる：発現システム、クローニングベクター。昆虫や細菌を用いたDNA発現の調査が活発化しており、同分野の需要に拍車がかかると予想されます。

用途別では、健康・疾患、食品・農業、環境、その他の4つに分類されます。健康・疾患分野が市場を独占しており、予測期間中もその優位性を維持するとみられます。ワクチン、医薬品、酵素代替品などの疾患治療に対する需要の高まりが市場成長を促進しています。

市場はエンドユーザー別に製薬・バイオテクノロジー企業、研究機関、その他の3つに分類されます。製薬・バイオテクノロジー企業が市場を独占しており、予測期間中もその優位性を維持するとみられます。新薬開発重視の高まりが同分野の成長に寄与するとみられます。

組換えDNA技術市場-地理的洞察

地理的には、この市場は北米、ラテンアメリカ、欧州、アジア太平洋、中東・アフリカの各地域に広がっています。これらの地域は、ビジネスを展開する国によってさらに分けられます。予測期間中、北米が市場を独占すると見られています。米国は北米で最大の市場シェアを占めているが、その主な理由は、多数のバイオ医薬品製造企業が存在し、技術利用を取り巻くさまざまな倫理的・科学的問題に目を光らせるための強力な規制機関が存在するためです。これにより、特に北米での市場拡大が促進されると予想されます。

組換えDNA技術市場-競合情勢：

組換えDNA技術市場は、その性質上、適度に断片化されています。多くのライフサイエンス領域でサービスを提供するため、各社は提携を結んでいます。また、市場競争力を維持するための現実的な戦術として、各社は絶えず生産設備を増強しています。戦略には、合併・買収、提携、製品開発などがあります。

目次

第1章 組換えDNA技術市場概要

  • 調査範囲
  • 市場推定年数

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 組換えDNA技術の主要な市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 今後の市場動向

第4章 組換えDNA技術産業調査

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しのマッピング
  • 規制枠組みの分析

第5章 組換えDNA技術市場：COVID-19影響分析

  • COVID-19以前の影響分析
  • COVID-19以後の影響分析

第6章 組換えDNA技術市場情勢

  • 組換えDNA技術市場シェア分析、2022年
  • 主要メーカー別の内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 組換えDNA技術市場- 構成要素別

  • 概要
    • 構成要素別のセグメントシェア分析
    • 発現システム
    • クローニングベクター

第8章 組換えDNA技術市場- 用途別

  • 概要
    • 用途別のセグメントシェア分析
    • 健康・疾患
    • 食品・農業
    • 環境
    • その他

第9章 組換えDNA技術市場- エンドユーザー別

  • 概要
    • エンドユーザー別のセグメントシェア分析
    • 製薬・バイオテクノロジー企業
    • 研究機関
    • その他

第10章 組換えDNA技術市場- 地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • アジア太平洋の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東とアフリカ
    • 概要
    • 中東とアフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第11章 主要ベンダー分析- 組換えDNA技術産業

  • 競合ダッシュボード
  • 企業プロファイル
    • F. Hoffmann-La Roche Ltd.
    • Profacgen
    • Amgen Inc
    • Novartis AG
    • GenScript
    • Pfizer Inc
    • Novo Nordisk A/S
    • Eli Lilly and Company
    • Sanofi
    • Merck &Co., Inc.
    • Biogen
    • Biocon
    • GlaxoSmithKline plc
    • New England Biolabs
    • Cibus
    • Monsanto Company
    • Horizon Discovery Group PLC
    • Others

第12章 アナリストの全方位展望

図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Recombinant DNA Technology Market: Component Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Component
  • TABLE Global Recombinant DNA Technology Market, by Component 2018-2030 (USD Million)
  • TABLE Recombinant DNA Technology Market: Application Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Recombinant DNA Technology Market, by Application 2018-2030 (USD Million)
  • TABLE Recombinant DNA Technology Market: End-User Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by End-User
  • TABLE Global Recombinant DNA Technology Market, by End-User 2018-2030 (USD Million)
  • TABLE Recombinant DNA Technology Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Recombinant DNA Technology Market, by Region 2018-2030 (USD Million)
  • TABLE North America Recombinant DNA Technology Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Recombinant DNA Technology Market, by Component, 2018-2030 (USD Million)
  • TABLE North America Recombinant DNA Technology Market, by Application, 2018-2030 (USD Million)
  • TABLE North America Recombinant DNA Technology Market, by End-User, 2018-2030 (USD Million)
  • TABLE Europe Recombinant DNA Technology Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Recombinant DNA Technology Market, by Component, 2018-2030 (USD Million)
  • TABLE Europe Recombinant DNA Technology Market, by Application, 2018-2030 (USD Million)
  • TABLE Europe Recombinant DNA Technology Market, by End-User, 2018-2030 (USD Million)
  • TABLE Asia Pacific Recombinant DNA Technology Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Recombinant DNA Technology Market, by Component, 2018-2030 (USD Million)
  • TABLE Asia Pacific Recombinant DNA Technology Market, by Application, 2018-2030 (USD Million)
  • TABLE Asia Pacific Recombinant DNA Technology Market, by End-User, 2018-2030 (USD Million)
  • TABLE Latin America Recombinant DNA Technology Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Recombinant DNA Technology Market, by Component, 2018-2030 (USD Million)
  • TABLE Latin America Recombinant DNA Technology Market, by Application, 2018-2030 (USD Million)
  • TABLE Latin America Recombinant DNA Technology Market, by End-User, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Recombinant DNA Technology Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Recombinant DNA Technology Market, by Component, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Recombinant DNA Technology Market, by Application, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Recombinant DNA Technology Market, by End-User, 2018-2030 (USD Million)

List of Figures

  • FIGURE Recombinant DNA Technology Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2022
  • FIGURE Component segment market share analysis, 2022 & 2030
  • FIGURE Component segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Application segment market share analysis, 2022 & 2030
  • FIGURE Application segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE End-User segment market share analysis, 2022 & 2030
  • FIGURE End-User segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Regional segment market share analysis, 2022 & 2030
  • FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE North America Recombinant DNA Technology Market share and leading players, 2022
  • FIGURE Europe Recombinant DNA Technology Market share and leading players, 2022
  • FIGURE Asia Pacific Recombinant DNA Technology Market share and leading players, 2022
  • FIGURE Latin America Recombinant DNA Technology Market share and leading players, 2022
  • FIGURE Middle East and Africa Recombinant DNA Technology Market share and leading players, 2022
  • FIGURE North America market share analysis by country, 2022
  • FIGURE U.S. Recombinant DNA Technology Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Canada Recombinant DNA Technology Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Europe Recombinant DNA Technology Market share analysis by country, 2022
  • FIGURE Germany Recombinant DNA Technology Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Spain Recombinant DNA Technology Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Italy Recombinant DNA Technology Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE France Recombinant DNA Technology Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE UK Recombinant DNA Technology Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Russia Recombinant DNA Technology Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Netherlands Recombinant DNA Technology Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Sweden Recombinant DNA Technology Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Poland Recombinant DNA Technology Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of the Europe Recombinant DNA Technology Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Asia Pacific Recombinant DNA Technology Market share analysis by country, 2022
  • FIGURE India Recombinant DNA Technology Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE China Recombinant DNA Technology Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Japan Recombinant DNA Technology Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE South Korea Recombinant DNA Technology Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Australia Recombinant DNA Technology Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Thailand Recombinant DNA Technology Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Indonesia Recombinant DNA Technology Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Phillipines Recombinant DNA Technology Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of APAC Recombinant DNA Technology Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Recombinant DNA Technology Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Recombinant DNA Technology Market share analysis by country, 2022
  • FIGURE Brazil Recombinant DNA Technology Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Mexico Recombinant DNA Technology Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Argentina Recombinant DNA Technology Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Colombia Recombinant DNA Technology Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of LATAM Recombinant DNA Technology Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Recombinant DNA Technology Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Recombinant DNA Technology Market share analysis by country, 2022
  • FIGURE Saudi Arabia Recombinant DNA Technology Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE United Arab Emirates Recombinant DNA Technology Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Israel Recombinant DNA Technology Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Turkey Recombinant DNA Technology Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Algeria Recombinant DNA Technology Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Egypt Recombinant DNA Technology Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of MEA Recombinant DNA Technology Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
目次
Product Code: ANV2187

REPORT HIGHLIGHT

Recombinant DNA Technology Market size was valued at USD 733,413 Million in 2022, expanding at a CAGR of 6.5% from 2023 to 2030.

The use of recombinant DNA technology has transformed medicine and is steadily influencing clinical practice. By substituting healthy genes with damaged and ill ones, it has made illness treatment easier. It is anticipated that DNA technology will grow as related technologies, such genome editing in plant tissue engineering, become more widely used.

Recombinant DNA Technology Market- Market Dynamics

Increasing demand for production of recombinant drugs and therapeutics to propel market demand

Increasing production of recombinant DNA with the rise in demand for recombinant drugs and therapeutics to fuel the market growth. Biotech and pharmaceutical companies are working to understand how rDNA methods might be applied to many areas of disease control. This is primarily to keep up with the expanding demand for treatments and fight the rising burden of chronic diseases. The presence of a robust biopharmaceuticals pipeline, in particular, the recombinant proteins pipeline; is likely to drive the use of this technology. Development of recombinant products employing rDNA techniques accompanied by CRISPR/Cas9 nuclease, ZFN, and TALEN enabling easy & precise genome editing with no limitation by organisms is significantly responsible for the expansion of this field.

The industry's advancements in the treatment of serious human illnesses like cancer, diabetes, and infectious diseases are some of the key elements influencing the market's growth. Novel molecular medicine, gene therapy, and the creation of long-acting therapeutic proteins for drug development have all benefited from advances in recombinant technologies. Moreover, improvements in the management of genetic illnesses and ongoing developments are anticipated to bolster market growth over the forecast period.

Recombinant DNA Technology Market- Key Insights

As per the shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 6.5% over the forecast period (2023-2030)

Based on Component, expression system segment was predicted to show maximum market share in the year 2022, due to its efficient protein expression capabilities.

Based on Application segmentation, health & disease segment was the leading segment in 2022, due to major demand for disease treatment such as drugs, vaccines, etc.

Based on End-User segmentation, pharmaceutical & biotech companies' segment was the leading segment in 2022, mainly due to growing number of drug developments.

On the basis of region, North America was the leading revenue generator in 2022, owing to supportive government regulations.

Recombinant DNA Technology Market- Segmentation Analysis:

The Global Recombinant DNA Technology Market is segmented on the basis of Component, Application, End-User, and Region.

The market is divided into two categories based on Component: expression system, and cloning vector. The epoxy-based segment dominates the market. Growing research in DNA expressions with insects, bacteria is expected to spur segment demand.

The market is divided into four categories based on Application: health & disease, food & agriculture, environment, and others. The health & disease segment dominates the market and is likely to maintain its dominance during the forecast period. The rising demand for disease treatment such as vaccine, drugs, and enzymes replacements is thriving market growth.

The market is divided into three categories based on End-User: pharmaceutical & biotech companies, research institutes, and others. The pharmaceutical & biotech companies segment dominates the market and is likely to maintain its dominance during the forecast period. The rise in emphasis on new drug development is expected to contribute to segment growth.

Recombinant DNA Technology Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. North America is expected to dominate the market over the forecast period. The United States has the biggest market share in North America, mostly owing to the home to a large number of biopharmaceutical manufacturing companies and has strong regulatory agencies in place to keep an eye on the various ethical and scientific issues surrounding the use of technology. It is anticipated that this will propel market expansion, particularly in North America.

Recombinant DNA Technology Market- Competitive Landscape:

Recombinant DNA technology market is moderately fragmented in nature. To provide their services in the many life science domains, market companies are forming cooperative alliances. Additionally, companies are constantly growing their production facilities as a practical tactic to maintain their competitiveness in the market. Some of the strategies include mergers & acquisition, collaboration, product development, etc.

Recent Developments:

In December 2022, Amgen Inc. an American transnational biopharmaceutical company acquired Horizon rectifiers plc. to expand their product line.

In March 2022, VBI Vaccines Inc. issued PreHevbrio a Recombinant Hepatitis B Vaccine in the United States for the forestallment of infection.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL RECOMBINANT DNA TECHNOLOGY MARKET KEY PLAYERS

  • F. Hoffmann-La Roche Ltd.
  • Profacgen
  • Amgen Inc
  • Novartis AG
  • GenScript
  • Pfizer Inc
  • Novo Nordisk A/S
  • Eli Lilly and Company
  • Sanofi
  • Merck & Co., Inc.
  • Biogen
  • Biocon
  • GlaxoSmithKline plc
  • New England Biolabs
  • Cibus
  • Monsanto Company
  • Horizon Discovery Group PLC
  • Others

GLOBAL RECOMBINANT DNA TECHNOLOGY MARKET, BY COMPONENT

  • Expression System
  • Cloning Vector

GLOBAL RECOMBINANT DNA TECHNOLOGY MARKET, BY APPLICATION

  • Health & disease
  • Food & agriculture
  • Environment
  • Others

GLOBAL RECOMBINANT DNA TECHNOLOGY MARKET, BY END-USER

  • Pharmaceutical & biotech companies
  • Research institutes
  • Others

GLOBAL RECOMBINANT DNA TECHNOLOGY MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Recombinant DNA Technology Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Recombinant DNA Technology Market Snippet by Component
    • 2.1.2. Recombinant DNA Technology Market Snippet by Application
    • 2.1.3. Recombinant DNA Technology Market Snippet by End-User
    • 2.1.4. Recombinant DNA Technology Market Snippet by Country
    • 2.1.5. Recombinant DNA Technology Market Snippet by Region
  • 2.2. Competitive Insights

3. Recombinant DNA Technology Key Market Trends

  • 3.1. Recombinant DNA Technology Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Recombinant DNA Technology Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Recombinant DNA Technology Market Opportunities
  • 3.4. Recombinant DNA Technology Market Future Trends

4. Recombinant DNA Technology Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Recombinant DNA Technology Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Recombinant DNA Technology Market Landscape

  • 6.1. Recombinant DNA Technology Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Recombinant DNA Technology Market - By Component

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Component, 2022 & 2030 (%)
    • 7.1.2. Expression System
    • 7.1.3. Cloning Vector

8. Recombinant DNA Technology Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2022 & 2030 (%)
    • 8.1.2. Health & disease
    • 8.1.3. Food & agriculture
    • 8.1.4. Environment
    • 8.1.5. Others

9. Recombinant DNA Technology Market - By End-User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End-User, 2022 & 2030 (%)
    • 9.1.2. Pharmaceutical & biotech companies
    • 9.1.3. Research institutes
    • 9.1.4. Others

10. Recombinant DNA Technology Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Recombinant DNA Technology Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Recombinant DNA Technology Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Recombinant DNA Technology Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Recombinant DNA Technology Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Recombinant DNA Technology Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- Recombinant DNA Technology Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. F. Hoffmann-La Roche Ltd.
    • 11.2.2. Profacgen
    • 11.2.3. Amgen Inc
    • 11.2.4. Novartis AG
    • 11.2.5. GenScript
    • 11.2.6. Pfizer Inc
    • 11.2.7. Novo Nordisk A/S
    • 11.2.8. Eli Lilly and Company
    • 11.2.9. Sanofi
    • 11.2.10. Merck & Co., Inc.
    • 11.2.11. Biogen
    • 11.2.12. Biocon
    • 11.2.13. GlaxoSmithKline plc
    • 11.2.14. New England Biolabs
    • 11.2.15. Cibus
    • 11.2.16. Monsanto Company
    • 11.2.17. Horizon Discovery Group PLC
    • 11.2.18. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us